This announcement is a separate document:
歐康維視生物-B：(1) 建議採納2021年購股權計劃；(2) 建議根據2021年購股權計劃授出購股權；(3) 有關建議根據2021年股份獎勵計劃授出獎勵之關連交易；(4) 建議授出關連授出特別授權及獎勵計劃特別授權；及(5) 股東特別大會通告
Ocumension Therapeutics-B: (1) PROPOSED ADOPTION OF THE 2021 SHARE OPTION SCHEME; (2) PROPOSED GRANT OF OPTIONS UNDER THE 2021 SHARE OPTION SCHEME; (3) CONNECTED TRANSACTION INVOLVING PROPOSED GRANT OF AWARDS UNDER THE 2021 SHARE AWARD SCHEME; (4) PROPOSE
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.